- Health & Pharmaceuticals›
- State of Health›
Five-year survival rates for prostate and testicular cancer U.S. 1975-2014
Five-year survival rates for prostate and testicular cancer U.S. 1975-2014
Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014
This statistic shows the five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014. From 2008 to 2014, the chances that a male in the U.S. diagnosed with prostate cancer would survive the first five years after diagnosis was 99 percent.
Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014
Loading statistic...
| Prostate cancer | Testicular cancer | |
|---|---|---|
| 2008 to 2014 | 99% | 97% |
| 1987 to 1989 | 83% | 95% |
| 1975 to 1977 | 68% | 83% |
| Prostate cancer | Testicular cancer | |
|---|---|---|
| 2008 to 2014 | 99% | 97% |
| 1987 to 1989 | 83% | 95% |
| 1975 to 1977 | 68% | 83% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014. From 2008 to 2014, the chances that a male in the U.S. diagnosed with prostate cancer would survive the first five years after diagnosis was 99 percent.
Show more- Show sources information
- Show publisher information
- Release date
- January 2019
- Region
- United States
- Survey time period
- 1975 to 2014
Source
- Show sources information
- Show publisher information
- Release date
- January 2019
More information
- Region
- United States
- Survey time period
- 1975 to 2014
Other statistics on the topic
Prostate cancer in the U.S.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Prostate cancer in the U.S.
- 75 page/s
- English
- pptx
- Detailed references
Everything On "Prostate cancer in the U.S." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Prostate cancer in the U.S."
- Overview
The most important statistics
- Percentage of men in the U.S. with prostate cancer who were diagnosed at select stages as of 2018Stage at diagnosis among U.S. men with prostate cancer as of 2018
- Percentage of men in the U.S. with prostate cancer who stated prostate cancer had select impacts on their quality of life as of 2018Impacts of prostate cancer on life quality among U.S. men as of 2018
- Percentage of men in the U.S. with prostate cancer who stated select symptoms affected their daily life as of 2018Symptoms of prostate cancer that affected the daily lives of U.S. men as of 2018
- Incidence
The most important statistics
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)United States: incidence rates for cancer 2011-2015, by gender
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*U.S. number of cancer cases among men in 2009 and 2019
- Incidence rate of prostate cancer in the U.S. from 2011 to 2015, by ethnicity (per 100,000 population)Rate of prostate cancer among U.S. males 2011-2015, by ethnicity
- Number of new prostate cancer cases in the U.S. in 2015, by state (per 100,000 population)Prostate cancer incidence rate in the U.S. in 2015, by state
- Probability of developing prostate cancer in the U.S. from 2013 to 2015, by age Chance of developing prostate cancer in the U.S. 2013-2015, by age
- Survival rates
The most important statistics
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancerCancer: 5-year survival rates in the U.S. 2008-2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014Five-year survival rates for prostate and testicular cancer U.S. 1975-2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 2008 to 2014, by stage at diagnosisFive-year survival rates for prostate and testicular cancer U.S. 2008-2014, by stage
- Deaths
The most important statistics
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by diseasePercentage changes in selected causes of death in the U.S. 2000-2017
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)U.S. death rates from cancer by type and gender 2012-2016
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer typeU.S. number of cancer deaths among men 2009 and 2019
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by prostate cancer in the U.S. 1950-2016
- Number of deaths due to prostate cancer in the United States from 1999 to 2015Number of deaths due to prostate cancer in U.S. 1999-2015
- Death rate for prostate cancer in the U.S. from 2012 to 2016, by ethnicity (per 100,000 population)Prostate cancer death rate in the U.S. 2012-2016, by ethnicity
- Number of prostate cancer deaths in the U.S. in 2015, by state (per 100,000 population)Prostate cancer death rate in the U.S. in 2015, by state
- Screening
The most important statistics
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ageProstate cancer test among men aged 50 years and older in the U.S. 2015, by age
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ethnicityProstate cancer test among men aged 50 years and older in the U.S. 2015, by ethnicity
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by educationProstate cancer test among men aged 50 years and older in the U.S. 2015, by education
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by regionProstate cancer test among men aged 50 years and older in the U.S. 2015, by region
- Treatment
The most important statistics
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012Distribution of treatment types for prostate cancer 2010-2012
- Medicines in development for cancer in the United States as of 2018, by all types*Medicines in development for cancer in the United States 2018
- Out-of-pocket costs per Medicare Part D retail prescription by therapy area in 2018 (in U.S. dollars)*Out of pocket costs of Medicare Part D retail prescription by drug therapy 2018
- Hospital care
The most important statistics
- Number of inpatient and outpatient cases per U.S. hospital by selected disease in 2016*Average inpatient and outpatient cases per hospital in the U.S. by disease 2016
- Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*Medicare inpatient hospital ALOS in U.S. cases by disease and IDN status 2016
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)Inpatient average length of stay in U.S. hospitals by cancer type 2008-2016
- Distribution of inpatient cases per hospital in the United States in 2016, by payer type and disease*Inpatient case share per U.S. hospital by insurance type and disease 2016
- Percent of inpatient charges reimbursed by Medicare by select condition in 2016*Medicare reimbursements of inpatient charges in the U.S. by condition 2016
- Average charge per inpatient case in U.S. acute-care hospitals by condition in 2016 (in U.S. dollars)*Charges for inpatients in U.S. hospitals per case by condition 2016
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Number of new Canadian prostate cancer cases in males by age group 2017
- Age-standardized death rate of prostate cancer among Canadian males 1988-2017
- Number of Canadian prostate cancer deaths in males by age group 2017
- Survival rate from childhood cancer in Sweden 2018, by type
- Incidence rate of prostate cancer among Canadian males 1988-2017
- Age-specific mortality rate of prostate cancer Australia 2016
- South Korean five-year survival rates for various cancer types 2015
- Melanoma 5-year relative survival rate Australia 1985-2014
- Age-standardized mortality rate for prostate cancer Australia 1968-2016
- Prostate cancer cases rate per 100,000 population in England 1995-2016
- Newly diagnosed prostate cancer in England 1995-2016
- Prostate cancer cases in England 2016, by age
- Prostate cancer rate per 100,000 population in England 2016, by region
- Number of deaths from prostate cancer Australia 1968-2016
- Survival rate of newly established enterprises in Norway 2015, by establishing year
- Prostatic hyperplasia patient number in South Korea 2010-2020
- Facts on babies born before 37 weeks of gestation in the U.S. 2010
- Italy: number of femoropopliteal bypass surgeries 2010-2015
- Most common prescription drugs for prostatic hyperplasia South Korea 2016
- Average cost of male urinary and reproductive system procedures on the NHS UK 2016
Statistics on "Prostate cancer in the U.S."
- Percentage of men in the U.S. with prostate cancer who were diagnosed at select stages as of 2018
- Percentage of men in the U.S. with prostate cancer who stated prostate cancer had select impacts on their quality of life as of 2018
- Percentage of men in the U.S. with prostate cancer who stated select symptoms affected their daily life as of 2018
- Incidence rates for cancer in the United States for the period 2011-2015, by gender (per 100,000 population)
- Estimated number of new cancer cases among men in the U.S. in 2009 and 2019, by cancer type*
- Incidence rate of prostate cancer in the U.S. from 2011 to 2015, by ethnicity (per 100,000 population)
- Number of new prostate cancer cases in the U.S. in 2015, by state (per 100,000 population)
- Probability of developing prostate cancer in the U.S. from 2013 to 2015, by age
- Five-year relative cancer survival rates in the U.S. for the period 2008-2014, by type of cancer
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 1975 to 2014
- Five-year relative survival rates for prostate and testicular cancer in the U.S. from 2008 to 2014, by stage at diagnosis
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by disease
- Cancer death rates in the United States for the period 2012-2016, by type and gender (per 100,000 population)
- Estimated number of cancer deaths among men in the U.S. in 2009 and 2019, by cancer type
- Deaths by prostate cancer in the U.S. from 1950 to 2016 (per 100,000 population)
- Number of deaths due to prostate cancer in the United States from 1999 to 2015
- Death rate for prostate cancer in the U.S. from 2012 to 2016, by ethnicity (per 100,000 population)
- Number of prostate cancer deaths in the U.S. in 2015, by state (per 100,000 population)
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by age
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by ethnicity
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by education
- Percentage of men aged 50 years and older who had a prostate cancer test in the U.S. as of 2015, by region
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012
- Medicines in development for cancer in the United States as of 2018, by all types*
- Out-of-pocket costs per Medicare Part D retail prescription by therapy area in 2018 (in U.S. dollars)*
- Number of inpatient and outpatient cases per U.S. hospital by selected disease in 2016*
- Average length of Medicare inpatient hospital stays by disease in 2016, by IDN status (in days)*
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)
- Distribution of inpatient cases per hospital in the United States in 2016, by payer type and disease*
- Percent of inpatient charges reimbursed by Medicare by select condition in 2016*
- Average charge per inpatient case in U.S. acute-care hospitals by condition in 2016 (in U.S. dollars)*
- Estimated number of new prostate cancer cases among males in Canada by age group in 2017
- Age-standardized prostate cancer mortality rate among males in Canada from 1988 to 2017 (per 100,000 population)
- Estimated number of prostate cancer deaths among males in Canada by age group in 2017
- Survival rate from childhood cancer in Sweden in 2018, by type
- Age-standardized prostate cancer incidence rate among males in Canada from 1988 to 2017 (per 100,000 population)
- Age-specific mortality rate of prostate cancer in Australia in 2016
- Five-year survival rates for select cancers in South Korea as of 2015
- Melanoma skin cancer 5-year relative survival rate in Australia from 1985 to 2014
- Age-standardized mortality rate for prostate cancer in Australia from 1968 to 2016
- Rate of newly diagnosed cases of prostate cancer per 100,000 population in England from 1995 to 2016*
- Registration of newly diagnosed prostate cancer incidents in England from 1995 to 2016*
- Registrations of newly diagnosed cases of prostate cancer in England in 2016, by age group*
- Rate of newly diagnosed cases of prostate cancer per 100,000 population in England in 2016, by region*
- Number of deaths from prostate cancer in Australia from 1968 to 2016
- Survival rate of newly established enterprises in Norway as of 2015, by year of establishing
- Number of patients with benign prostatic hyperplasia (BPH) in South Korea from 2010 to 2020 (in thousands)
- Key facts on survival of babies born before 37 weeks of gestation in the United States in 2010
- Number of femoropopliteal bypass surgeries performed during hospital recovery in Italy in 2010 and 2015 (per 100,000 population)
- Sales value of the 10 most prescribed medications for benign prostatic hyperplasia (BPH) in South Korea in 2016 (in million U.S. dollars)
- Average cost of male urinary and reproductive system procedures on the NHS in the United Kingdom (UK) in 2016 (in GBP)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.